This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, M. J.
Right arrow Articles by Haribabu, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, M. J.
Right arrow Articles by Haribabu, B.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2004, p. 936-941, Vol. 11, No. 5
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.5.936-941.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Leukotriene B4 Receptor (BLT-1) Modulates Neutrophil Influx into the Peritoneum but Not the Lung and Liver during Surgically Induced Bacterial Peritonitis in Mice

Melanie J. Scott,1 William G. Cheadle,2,3,4* J. Jason Hoth,5 James C. Peyton,4 Krishnaprasad Subbarao,3 Wen-Hai Shao,3 and Bodduluri Haribabu3,6

Departments of Surgery,2 Microbiology and Immunology, University of Louisville School of Medicine,3 Veterans Affairs Medical Center,4 James Graham Brown Cancer Center, Louisville, Kentucky,6 Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania,1 Department of Surgery, Wake Forest University, Winston-Salem, North Carolina5

Received 6 April 2004/ Returned for modification 22 May 2004/ Accepted 19 June 2004

Leukotriene B4 (LTB4) is a rapidly synthesized, early neutrophil chemoattractant that signals via its cell surface receptor, BLT-1, to attract and activate neutrophils during peritonitis. BLT-1-deficient (BLT-1–/–) mice were used to determine the effects of LTB4 on neutrophil migration and activation, bacterial levels, and survival after cecal ligation and puncture (CLP). Male BLT-1–/– or wild-type (WT) BALB/c mice underwent CLP. Tissues were harvested for determination of levels of bacteria, myeloperoxidase (MPO), LTB4, macrophage inflammatory protein 2 (MIP-2), and neutrophil (polymorphonuclear leukocyte [PMN]) numbers at 4 and 18 h after CLP. PMN activation was determined by an assessment of phagocytosis ability and CD11b expression. Survival was also determined. BLT-1–/– mice had decreased numbers of PMNs in the peritoneum at both 4 and 18 h after CLP but increased numbers of PMNs in the blood at 18 h compared with WT mice. Liver and lung MPO levels were significantly higher in BLT-1–/– mice at both 4 and 18 h after CLP, with increased bacterial levels in the blood, the liver, and peritoneal fluid at 4 h. Bacterial levels remained higher in peritoneal fluid at 18 h, but blood and liver bacterial levels at 18 h were not different from levels at 4 h. PMN phagocytosis and CD11b levels were decreased in BLT-1–/– mice. LTB4 levels were similar between the groups before and after CLP, but MIP-2 levels were decreased both locally and systemically in BLT-1–/– mice. Survival was significantly improved in BLT-1–/– mice (71%) compared with WT mice (14%) at 48 h post-CLP. Thus, LTB4 modulates neutrophil migration into the mouse peritoneum, but not the lung or liver, after CLP. Despite higher bacterial and PMN levels at remote sites, there was increased survival in BLT-1–/– mice compared to WT mice. Decreased PMN activation may result in less remote organ dysfunction and improved survival.


* Corresponding author. Mailing address: Department of Surgery, University of Louisville, Louisville, KY 40292. Phone: (502) 852-6230. Fax: (502) 852-8915. E-mail: wg.cheadle{at}louisville.edu.


Clinical and Diagnostic Laboratory Immunology, September 2004, p. 936-941, Vol. 11, No. 5
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.5.936-941.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.